HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Robert T Foreman Selected Research

N1- (4- (3- isopropyl- 2- methylindazol- 5- yl)pyrimidin- 2- yl)- N4- tetrahydropyran- 4- yl- cyclohexane- 1,4- diamine

6/2014A novel CDK9 inhibitor shows potent antitumor efficacy in preclinical hematologic tumor models.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Robert T Foreman Research Topics

Disease

3Neoplasms (Cancer)
12/2019 - 06/2014
1Polyploidy
12/2019
1Aneuploidy (Aneuploid)
12/2019
1Leukemia
06/2014

Drug/Important Bio-Agent (IBA)

2Phosphotransferases (Kinase)IBA
12/2019 - 06/2014
1Protein Isoforms (Isoforms)IBA
12/2019
1Folic Acid (Vitamin M)FDA LinkGeneric
10/2018
1purineIBA
10/2018
1AICA ribonucleotide (ZMP)IBA
10/2018
1N1- (4- (3- isopropyl- 2- methylindazol- 5- yl)pyrimidin- 2- yl)- N4- tetrahydropyran- 4- yl- cyclohexane- 1,4- diamineIBA
06/2014
1Proteins (Proteins, Gene)FDA Link
06/2014

Therapy/Procedure

1Oral Administration
10/2018